Verséa Discovery, Inc. Announces the Official Launch of mescreen™ Research Validator – a Revolutionary Mitochondrial Compound Assessment Platform
August 27, 2024by Verséa Health, Inc.
8/27/2024, Tampa, FL – Verséa Discovery, Inc., a Florida-based company dedicated to advancing scientific research and development in the area of personalized and precision medicine, has announced the official launch of mescreen™ Research Validator. The mescreen™ Research Validator is a groundbreaking, proprietary compound assessment platform that harnesses mitochondrial function and dynamics to generate critical data,...